Webinar – Materiovigilance – All about the new European Regulation on Medical Devices (REU 2017/745)
Universal Medica pleased to announce its next webinar « Materiovigilance – All about the new European Regulation on Medical Devices (REU 2017/745) » 📅 Wednesday December 2nd, 10am to 10.45am (central european time) Our experts will discuss the following points : • How to implement post-market MD surveillance and what data to monitor? • How is incident reporting notification carried out? • What are the…
For October Rose, all Universal Medica Group employees have mobilised in the fight against breast cancer. Every year, nearly 58,000 cases and 12,000 deaths are reported in France (1). If detected at an early stage, breast cancer can be cured in 90% of cases (2). This is why, throughout this month, our teams have been campaigning to send out messages to raise awareness about screening….
7 key points for a successful pharmacovigilance inspection
On 18/06/2020 at 17h30 (30 minutes).
Pharmacovigilance is one of the cornerstones of a drug’s life. On a daily basis, it enables the monitoring and prevention of the risk of adverse effects resulting from their use. The announcement of a pharmacovigilance inspection is an important step in the life of a pharmaceutical laboratory…
5 key steps to manage crisis management in the pharmaceutical industry*
On 25/06/2020 at 17H30 (30 minutes)
Pharmaceutical companies are confronted with crisis situations that can have major consequences in terms of image, reputation and relationships with their direct or indirect customers. Whatever the type of crisis to be managed (shortage, industrial accident, unexpected adverse reaction, health crisis…)
On 5th November 2019, two representatives from California (Silicon Valley, USA) proposed the implementation of an ‘American version’ of GDPR. This proposed law, known as the Online Privacy Act, would have the same goal as the General Data Protection Regulation (GDPR): the protection of citizens. Universal Medica Group, through the concept we have developed ‘GDPR for life science’, ensures the management and protection of data,…
In march 2019, Universal Medica Group and EVERSANA have entered into a partnership to provide medical information and pharmacovigilance services throughout Europe, Asia and North, Central and South America. This strategic collaboration meets the evolving needs of Global clients. As a single, integrated service partner EVERSANA and Universal Medica Group deliver programs with the infrastructure, technology, worflows and clinical staffing needed to effectively and efficiently…
UNIVERSAL MEDICA GROUP and EVERSANA announce global medical information and pharmacovigilance service partnership
Universal Medica Group and EVERSANA today are pleased to announce that they have entered into a definitive partnership, increasing their global footprint and enhancing their expertise in the life sciences and healthcare industry. Universal Medica Group, an expert in healthcare and pharmaceutical services, will partner with EVERSANA, the leading independent provider of full commercial services to the life science industry, and together, the companies take…
Universal Medica Group (UMG) has reached a new stage in its development with the acquisition of BBac, a company specializing in pharmacovigilance and safety in the healthcare industry. This acquisition is part of the “Horizon 2020” strategic plan, which responds to the industry transformations and to needs of healthcare industry evolutions to promote the healthcare products proper use, safety and efficacy for patients’ benefit. An…
Presentation I am a pharmacist (PharmD) and I have a University thesis in PharmacoEpidemiology (PhD). Afterwards, I worked during 15 years as a practitioner in the Regional Center of Pharmacovigilance (CRPV) of Toulouse before joining Universal Medica as Pharmacovigilance Manager (PV). During these 15 years, I carried out numerous appraisals for the ANSM, in particular in oncology. What is your role as a Pharmacovigilance Manager?…
Attracted by the Healthcare sector for a long time, after graduating with my doctorate in microbiology, I decided to enter the pharmaceutical industry and in particular to commit into concrete activities in connection with healthcare professionals and patients. This is how I joined Universal Medica as an attached scientist. In two years, I had a promotion opportunity with a project manager’s position. What is…